ARTICLE | Clinical News
Bcell-HDM regulatory update
February 26, 2001 8:00 AM UTC
BTRN said Eligix received CE mark authorization for its BCell High Density Microparticle (HDM) cell separation device to treat B cell malignancies that are normally treated with bone marrow transplant...